146 related articles for article (PubMed ID: 8619598)
1. Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: evaluation of current treatment.
Walsh AL; Smith MD; Wuthiekanun V; White NJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2356-8. PubMed ID: 8619598
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies.
Smith MD; Wuthiekanun V; Walsh AL; White NJ
J Antimicrob Chemother; 1994 Jan; 33(1):145-9. PubMed ID: 7512547
[No Abstract] [Full Text] [Related]
3. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
Schweizer HP
Future Microbiol; 2012 Dec; 7(12):1389-99. PubMed ID: 23231488
[TBL] [Abstract][Full Text] [Related]
5. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
6. In vitro interactions between cotrimoxazole and doxycycline in Burkholderia pseudomallei: how important is this combination in maintenance therapy of melioidosis?
Saraya S; Soontornpas C; Chindavijak B; Mootsikapun P
Indian J Med Microbiol; 2009; 27(1):88-9. PubMed ID: 19172079
[No Abstract] [Full Text] [Related]
7. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.
Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845
[TBL] [Abstract][Full Text] [Related]
8. The antibiotics of choice for the treatment of melioidosis in Indian set up.
Shaw T; Tellapragada C; Eshwara VK; Bhat HV; Mukhopadhyay C
Indian J Med Microbiol; 2016; 34(3):353-4. PubMed ID: 27514960
[TBL] [Abstract][Full Text] [Related]
9. In vitro antimicrobial susceptibility of clinical and environmental strains of Burkholderia pseudomallei from Brazil.
Bandeira Tde J; Brilhante RS; Rocha MF; Moreira CA; Cordeiro Rde A; Ribeiro JF; Castelo-Branco Dde S; Sidrim JJ
Int J Antimicrob Agents; 2013 Oct; 42(4):375-7. PubMed ID: 23993065
[No Abstract] [Full Text] [Related]
10. Evaluating New Compounds to Treat
Ross BN; Myers JN; Muruato LA; Tapia D; Torres AG
Front Cell Infect Microbiol; 2018; 8():210. PubMed ID: 30013953
[No Abstract] [Full Text] [Related]
11. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
[TBL] [Abstract][Full Text] [Related]
13. Activity of Ceftolozane-Tazobactam against
Slack A; Parsonson F; Cronin K; Engler C; Norton R
Am J Trop Med Hyg; 2018 Aug; 99(2):281-282. PubMed ID: 29943711
[TBL] [Abstract][Full Text] [Related]
14. An in situ high-throughput screen identifies inhibitors of intracellular
Bulterys PL; Toesca IJ; Norris MH; Maloy JP; Fitz-Gibbon ST; France B; Toffig B; Morselli M; Somprasong N; Pellegrini M; Schweizer HP; Tuanyok A; Damoiseaux R; French CT; Miller JF
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18597-18606. PubMed ID: 31439817
[No Abstract] [Full Text] [Related]
15. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
[TBL] [Abstract][Full Text] [Related]
16. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis.
Häussler S; Rohde M; Steinmetz I
Med Microbiol Immunol; 1999 Nov; 188(2):91-7. PubMed ID: 10753061
[TBL] [Abstract][Full Text] [Related]
17. Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei.
Thomas RJ; Hamblin KA; Armstrong SJ; Müller CM; Bokori-Brown M; Goldman S; Atkins HS; Titball RW
Int J Antimicrob Agents; 2013 Apr; 41(4):330-6. PubMed ID: 23402703
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Resistance to Folate Pathway Inhibitors in
Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.
Sivalingam SP; Sim SH; Aw LT; Ooi EE
J Antimicrob Chemother; 2006 Nov; 58(5):1102-3. PubMed ID: 16951412
[No Abstract] [Full Text] [Related]
20. Antibiotic resistance in Burkholderia species.
Rhodes KA; Schweizer HP
Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
